Photo from Pexels
Originally Posted On: https://bluefinvision.com/blog/when-a-patient-travels-for-excellence-you-have-to-do-the-work-that-makes-excellence-possible/
A case of bilateral posterior polar cataract, forme fruste keratoconus, and compromised biometry – and what thorough preparation actually looks like.
“Complexity is not about taking risks. It is about being prepared for them.”
Mr Mfazo Hove, Consultant Ophthalmic Surgeon
This case is not about complexity. It is about how complexity is managed.
The Patient
He had been cancelled on the day of surgery elsewhere. He had travelled from Birmingham. He could no longer drive legally. And he was sitting in front of us, keen for surgery – but not at any cost.
That last part matters. Patients who are desperate do not always advocate for themselves clearly. He did. He wanted to understand the risks. He wanted to know the plan. He wanted to proceed only if the clinical case for proceeding was sound.
That is the right patient for a case like this.
The Case
Three findings. Each significant in isolation. Together, they define a case where the margin for error was narrow from the outset.
Bilateral posterior polar cataracts
Posterior polar cataract is not simply another cataract. The posterior capsule in these cases may be thin, focally absent, or already dehiscent before a single instrument enters the eye. Posterior capsule rupture rates in posterior polar cataract surgery are substantially higher than in standard phacoemulsification – a consistent finding across the surgical literature.
- The cataract is adherent to the posterior capsule by definition ¹ ² ³ ⁴
- The capsule may dehisce at the moment of hydrodissection ¹ ²
- Standard surgical manoeuvres that are routine in other cases become high-risk here ³ ⁴
Anterior segment OCT: posterior polar cataract. The dense posterior polar opacity is clearly visible adherent to the posterior capsule. The relationship between the opacity and the capsule is the key preoperative risk indicator – this image demonstrates why optical biometry failed and why direct OCT visualisation of the posterior capsule was essential before surgical planning could proceed.
Forme fruste keratoconus
The topography demonstrated subclinical keratoconus – not visually significant, not a contraindication to cataract surgery, but a factor that changes the biometric approach, the IOL calculation strategy, and the refractive expectations that can reasonably be set.
- IOL power calculation in keratoconus is less predictable ⁸ ⁹ ¹⁰
- Posterior corneal irregularity affects keratometric readings and targets ⁸ ⁹
- Toric IOL planning requires additional caution in this corneal context ¹⁰
Unreliable optical biometry – right eye
The right eye did not yield usable optical biometry. In a standard case, this is a problem to be solved. In a case of posterior polar cataract with keratoconus, it narrows the margin for error in IOL selection at precisely the moment that margin matters most.
CASIA2 Topometric / KC-Staging: right eye. Belin ABCD staging A0 B0 C0.3 – forme fruste keratoconus. KI 1.11, CKI 1.00, KC1 flag. Asymmetric inferior steepening to 47.1D with normal anterior ABCD indices confirms subclinical disease.
The Biometry Decision Chain
When optical biometry fails, the instinct in a busy unit is to accept the A-scan result and proceed. That instinct is understandable. In a routine case, it is often reasonable. In this case, it was insufficient.
The sequence mattered at every step.
Step 1: Optical biometry – failed
The right eye did not yield usable optical biometry. Dense posterior polar cataract is a recognised cause of optical biometry failure – the posterior opacity disrupts the signal path. This was expected, not alarming. But it set the clinical problem.
What this means: we cannot calculate the IOL power from optical biometry alone. The clinical problem is defined. The solution has not yet been found.
Step 2: A-scan – obtained, but not accepted in isolation
Contact A-scan axial length was measured: average 24.90mm across ten readings (SD 0.04mm). A well-reproduced result. But A-scan measures shorter than optical biometry due to the difference in retinal endpoint detection – contact ultrasound measures to the internal limiting membrane, whereas optical biometry measures to the retinal pigment epithelium – a device- and technique-dependent difference typically in the range of 0.2–0.3mm.
The correction factor is approximately 0.2–0.3mm (device-dependent), bringing the effective optical equivalent to approximately 25.10–25.20mm. This cross-reference was the first clinical check.
What this means: the A-scan result is usable, but only after applying the known correction factor. It is a starting point, not a conclusion.
Contact A-scan: right eye. Average axial length 24.90mm (SD 0.04, ten measurements). 12.5MHz transducer. Well-reproduced result – but interpreted with the recognised offset of ~0.2–0.3mm relative to optical biometry (device- and technique-dependent) before IOL planning.
Step 3: Cross-referencing with the fellow eye and refraction
The left eye yielded reliable optical biometry: axial length 25.266mm. The corrected right eye A-scan estimate was approximately 25.20mm. The 0.07mm difference between the two eyes is clinically coherent with the bilateral refractive error – right eye SE −3.50D, left eye SE −3.50D. Symmetric myopia produces symmetric axial lengths. The numbers agreed.
The autorefraction provided independent corroboration. When refraction and biometry agree bilaterally, the measurement is more likely to be correct. When they diverge, that divergence is a signal worth investigating before IOL selection.
Optical biometry printout: left eye (Sonomed A-scan). Axial length 25.266mm – cross-reference for right eye A-scan interpretation. Consistent with bilateral SE −3.50D on autorefraction.
Autorefraction: right eye −3.00/−0.75 × 13 (SE −3.50D), left eye −2.50/−1.75 × 111 (SE −3.50D). Bilateral spherical equivalents identical – corroborating symmetric axial lengths and validating the A-scan/Revo reconciliation.
Step 4: Revo OCT biometry – right eye IOL calculation
With the A-scan corrected and cross-referenced, the patient was sent the same day to another Blue Fin Vision® site for Revo OCT biometry. This is not an external referral. It is the Blue Fin Vision® network operating as it was designed to – diagnostic resource shared across sites, in the patient’s interest, on the same day.
Two features of the Blue Fin Vision® infrastructure made this seamless. First, all sites operate on a single unified electronic patient record. The biometry obtained at the second site was immediately visible to the operating surgeon without any transfer of files, handwritten notes, or manual data entry. Second, all surgical cases are recorded as a matter of course. The intraoperative record from this case – including the image at the top of this article – exists in the system, reviewable and auditable. To achieve the immeasurable, you must measure everything: that principle extends to documentation, not only diagnostics.
The Revo served two purposes: to obtain an axial length measurement independent of the ultrasound offset, and, critically, to directly visualise the posterior capsule. This was the measurement used for IOL power calculation.
Revo OCT biometry: right eye – primary measurement used for IOL power calculation. Average axial length 25.38mm (SD 0.04mm, range 25.34–25.44mm, ten measurements). CCT 0.547mm. QI 8. Consistent with corrected A-scan estimate (~25.20mm) and left eye optical biometry (25.266mm). Posterior capsule directly visualised on OCT: intact.
Step 4: Revo OCT biometry – right eye IOL calculation
The Revo returned 25.38mm for the right eye – consistent with the corrected A-scan estimate (~25.20mm) and with the left eye optical biometry of 25.266mm. Three independent reference points converged. The right eye IOL calculation was performed on the Revo measurement. The left eye IOL calculation used its own optical biometry directly.
The posterior capsule appeared intact on direct OCT visualisation. This was the finding that changed the clinical pathway – not by eliminating risk, but by characterising it accurately. Anterior segment OCT in posterior polar cataract has been shown to identify cases at elevated risk of capsule rupture before surgery begins, allowing the surgical approach to be adjusted accordingly.
- Right eye: optical biometry failed → A-scan corrected to ~25.20mm → Revo OCT 25.38mm confirmed – cross-referenced against left eye optical biometry (25.266mm) and bilateral SE −3.50D ¹¹
- Bilateral SE identical at −3.50D: symmetric refraction corroborating symmetric anatomy
- Posterior capsule intact on OCT: risk stratified, not eliminated ⁵ ⁶ ⁷
- IOL power calculated on Revo measurement as primary input
What this means: no single measurement was trusted in isolation. Every number was cross-referenced against at least two independent sources before IOL selection. In our own audited practice, this discipline of measurement verification is applied without exception – including in cases where a single result would have been accepted elsewhere.
Clinical Principle
The goal of preoperative planning is not to eliminate uncertainty. It is to characterise it accurately. A surgeon who proceeds with incomplete information is not being efficient. They are transferring unquantified risk to the patient.
Plan A, Plan B, Plan C
Before the first incision, three contingency pathways were defined.
Plan A
Routine phacoemulsification – uneventful, no vitreoretinal input required. The expected outcome. Not the assumed one.
Plan B
Complicated anterior segment surgery – posterior capsule compromise managed intraoperatively without vitreoretinal intervention. Anterior vitrectomy if required. IOL placed in sulcus or anterior chamber as appropriate.
Plan C
Dropped nucleus. In-house vitreoretinal surgery with Professor Mahmut Dogramaci. No need for the patient to return from Birmingham – he had already planned to stay in London for a few days precisely because Plan C was a real possibility. Financially loss-making for the practice. Clinically necessary. Non-negotiable.
Posterior polar cataract is one of the highest-risk scenarios for intraoperative posterior capsule rupture and nucleus drop in the published literature.
- PCR rates in posterior polar surgery significantly exceed standard phacoemulsification benchmarks ¹ ² ³ ⁴
- Nucleus drop in this setting carries serious downstream risk – including retinal detachment ¹ ³
- Planning for Plan C is not pessimism. It is professionalism.
Blue Fin Vision® Answer
In-house vitreoretinal support is not a marketing statement. It is a structural contingency. Professor Mahmut Dogramaci is available for escalation on the same day or the following morning. For a patient who has travelled from Birmingham, that availability is not a convenience. It is the difference between one journey and several.
Surgery
Bilateral posterior polar cataract surgery was completed the following morning. Uneventfully.
No posterior capsule rupture. No dropped nucleus. No vitreoretinal intervention required.
This outcome was not the result of surgical confidence in isolation. It was the result of the work done before surgery began: the same-day Revo OCT biometry at another Blue Fin Vision® site, the posterior capsule assessment, the three contingency pathways, the in-house escalation contact named in the notes before consent was taken.
The surgery was routine because the preparation was not.
This Is Not an Exceptional Day. This Is the Standard.
The Blue Fin Vision® Doctrine is built on a single principle: to achieve the immeasurable, you must measure everything. This case is an illustration of that principle in action – but it is not an exception.
On the same day this patient was operated on, the Blue Fin Vision® list included:
- One only-eye patient – his fellow eye non-functional. No safety net. No second chance. A serious intraoperative complication would not mean a difficult recovery. It would mean the end of functional sight.
- Two vitrectomised eyes – each carrying elevated risk of capsule support compromise, altered vitreous dynamics, and adapted surgical technique
- One traumatic cataract – unpredictable zonular integrity, altered anatomy, no reliable preoperative reference point
- The bilateral posterior polar cataract case described in this article – two eyes, one patient, the same list
The only-eye patient carried the greatest jeopardy. For every other patient on that list, a serious intraoperative complication would mean a harder recovery and further surgery. For him, it would mean a categorically different life. He came to us because he wanted the best for his only eye. He stayed in London for several days afterwards – not as a precaution imposed on him, but as a decision he had already made. He understood that Plan C was a real possibility, and he had planned accordingly.
That is not a list assembled to demonstrate capability. It is a Friday list. The complexity is not selected for. It arrives because patients who have been cancelled elsewhere, told their case is too difficult, or who carry anatomy that most units will not operate on, find their way here.
The Blue Fin Vision® Advantage is not a marketing claim. It is the reason a patient travels from Birmingham on the day he was cancelled at another unit and stays in London while bilateral surgery is completed the following morning. It is the in-house vitreoretinal cover that makes a same-day list of this profile possible without a transfer pathway. It is the diagnostic infrastructure – across multiple Blue Fin Vision® sites – that allows a same-day Revo OCT to happen between listing and consent, without sending a patient to an external provider.
Patients are not coming to Blue Fin Vision® because we take on difficult cases. They are coming because we treat complex cases the way other units treat routine ones: with structure, with contingency, and without exception.
Blue Fin Vision® Doctrine
To achieve the immeasurable, you must measure everything. The preparation for this case – the biometry reconciliation, the same-day Revo OCT at a Blue Fin Vision® sister site, the posterior capsule assessment, the three contingency pathways, the named escalation contact – is not exceptional practice. It is the documented standard applied to every case on every list. Including the only-eye patient. Including the traumatic cataract. Including the vitrectomised eyes. The standard does not scale with risk. It is constant.
Why We Do Not Charge More for Complexity
This question comes up. We have considered it. We do not do it. The reasons are clinical, not commercial.
It distorts the patient’s understanding of risk
When a patient pays more, they may infer that more has been guaranteed. Biology does not work that way. A higher fee does not reinforce a fragile posterior capsule. Charging more for complexity creates an expectation that surgery cannot fulfil – and that mismatch is precisely where dissatisfaction originates in surgical practice.
It penalises anatomy
Posterior polar cataract is not a choice. Forme fruste keratoconus is not an upgrade. These are anatomical realities. Charging a patient more because their eye did not develop as it might have done is not a clinical position. It is a commercial one.
The airline principle
A 130 kg passenger costs more to fly than a 70 kg passenger. Unless two seats are required, the price is the same. We charge for the service. Not the patient’s biology.
Over time, the model balances. Straightforward cases are efficient. Complex cases are resource-intensive. The standard – advanced diagnostics, thorough counselling, and structured contingency planning – applies to both. What varies is the preparation required, not the commitment to deliver it.
The consultation fee is worth addressing directly. At Blue Fin Vision®, a surgical consultation for cataract or lens replacement surgery is allocated 45 minutes of protected consultant surgeon time, together with a comprehensive diagnostic pathway. This typically includes OCT (macula and optic nerve), anterior segment OCT / corneal topography, biometry (optical where possible, supplemented by A-scan ultrasound as needed), and endothelial cell count.
True delivered clinical value: over £1,400 based on our standard component pricing.
Fee charged: £500.
- 45-minute consultant surgeon consultation: £500
- OCT – macula and optic nerve: £200
- Anterior segment OCT / corneal topography: £200
- Biometry (optical): £200
- A-scan ultrasound biometry (where required): £150
- Endothelial cell count (ECC): £150
This £500 is not a deposit against surgical fees. It covers the surgeon’s time and the diagnostic foundation on which safe decisions are built – especially in cases like this one, where optical biometry failed in one eye, multiple independent measurements had to be reconciled, and direct visualisation of the posterior capsule was essential before listing for surgery.
We deliberately subsidise this pathway because thorough preoperative assessment should never be an optional extra. It is the clinical standard our Doctrine demands: to achieve the immeasurable, you must measure everything.
What “Difficult Cases” Actually Requires
Patients sometimes say they have come because we like difficult cases. That is not accurate. Difficult cases require more time, more responsibility, and more risk. What we offer is simpler than a preference for complexity.
We are willing to do the work those cases require.
That means the preoperative imaging that most clinics would not refer same-day. The contingency pathways defined before consent, not after a complication. The in-house escalation contact named in the patient’s notes before surgery begins. The financial willingness to absorb a loss-making outcome if Plan C is what the patient needs.
That is not complexity management. That is clinical standard applied without exception.
He travelled from Birmingham.
He had been cancelled the same day, elsewhere.
He left with bilateral surgery complete.
He was one case on a list that also included a patient with one functioning eye, two vitrectomised eyes, and a traumatic cataract.
The work that made all of it possible happened before any of them entered the theatre.
What Patients Should Look For
This case is documented in detail because the decisions made before surgery are invisible to most patients – and because those decisions are where safety is determined. Here is what the preoperative process should contain in a complex cataract case.
|
Factor
|
Why it matters
|
|---|---|
|
What made this case safe
|
Full diagnostic pathway before consent. Biometry verified across three independent sources. Posterior capsule directly visualised on OCT. Three surgical contingency pathways defined in advance. In-house vitreoretinal cover confirmed before listing.
|
|
What could have gone wrong
|
Accepting the A-scan without correction. Proceeding without capsule visualisation. No contingency for nucleus drop. No in-house vitreoretinal cover. Bilateral surgery attempted in a single sitting at a unit unable to manage Plan C.
|
|
What patients should ask
|
Who performs my biometry – and who interprets it? What happens if optical biometry fails? Has the posterior capsule been assessed preoperatively? What is the plan if there is a complication? Is vitreoretinal support available on the same site?
|
|
What the evidence shows
|
PCR rates in posterior polar cataract significantly exceed standard phacoemulsification benchmarks. ¹ ² ³ ⁴ Anterior segment OCT improves preoperative risk stratification. ⁵ ⁶ ⁷ Biometric discrepancy between ultrasound and optical devices is well documented and requires clinical reconciliation. ¹¹
|
References
- Vasavada AR, Singh R. Phacoemulsification in eyes with posterior polar cataract. J Cataract Refract Surg. 1999;25(2):238–245.
- Siatiri H, Moghimi S. Posterior polar cataract: minimizing risk of posterior capsule rupture. Eye (Lond). 2006;20(7):814–816.
- Das S, Khanna R, Mohiuddin SM, Ramamurthy B. Surgical and visual outcomes for posterior polar cataract. Br J Ophthalmol. 2008;92(11):1476–1478.
- Kumar S, Ram J, Sukhija J, Severia S. Phacoemulsification in posterior polar cataract: does size of lens opacity affect surgical outcome? Clin Exp Ophthalmol. 2010;38(9):857–861.
- Chan TCY, Li EYM, Yau JCYY. Application of anterior segment optical coherence tomography to identify eyes with posterior polar cataract at high risk for posterior capsule rupture. J Cataract Refract Surg. 2014;40(12):2076–2081.
- Kymionis GD, Diakonis VF, Liakopoulos DA, Tsoulnaras KI, Klados NE, Pallikaris IG. Anterior segment optical coherence tomography for demonstrating posterior capsular rent in posterior polar cataract. Clin Ophthalmol. 2014;8:215–217.
- Kumar GP, Krishnamurthy P, Nath M, Baskaran P, Janani M, Venkatesh R. Can preoperative anterior segment optical coherence tomography predict posterior capsule rupture during phacoemulsification in patients with posterior polar cataract? J Cataract Refract Surg. 2018;44(12):1441–1445.
- Moshirfar M, Walker BD, Birdsong OC. Cataract surgery in eyes with keratoconus: a review of the current literature. Curr Opin Ophthalmol. 2018;29(1):75–80.
- Singh C, Joshi VP. Cataract surgery in keratoconus revisited – an update on preoperative and intraoperative considerations and postoperative outcomes. Semin Ophthalmol. 2023;38(1):57–64.
- Watson MP, Anand S, Bhogal M, Gore DM, Naroo SA, Shah S. Cataract surgery outcome in eyes with keratoconus. Br J Ophthalmol. 2014;98(3):361–364.
- Pereira A, Popovic M, Lloyd JC, El-Defrawy S, Schlenker MB. Preoperative measurements for cataract surgery: a comparison of ultrasound and optical biometric devices. Int Ophthalmol. 2021;41(4):1521–1530.
ABOUT THE AUTHOR
Mr Mfazo Hove
Consultant Ophthalmic Surgeon
MBChB MD FRCOphth CertLRS
Mr Hove is a consultant ophthalmic surgeon who has performed more than 57,000 procedures. His training includes 6.5 years of specialist development at Moorfields Eye Hospital, followed by five years as a consultant at the Western Eye Hospital (Imperial College Healthcare NHS Trust). He is a consultant at Blue Fin Vision®, an elite ophthalmology clinic serving London, Essex and Hertfordshire, working alongside an experienced clinical team delivering comprehensive ophthalmic care. He specialises in cataract surgery and advanced vision correction, including laser procedures, lens replacement and implantable Collamer lenses (ICL).
Schedule Your Consultation Today
If you have been told your cataract case is too complex, or if you would like a thorough, consultant-led assessment before proceeding with surgery, we are here to help. Book a consultation with Mr Hove and the Blue Fin Vision® team to discuss your options. Every patient receives a comprehensive diagnostic pathway and a structured surgical plan – whether the case is straightforward or complex.
Blue Fin Vision® delivers consultant-led cataract surgery with documented outcomes across London, Hertfordshire, and Essex.
